USP5 and non-small cell lung carcinoma: The USP5 inhibitor G9 can lead to cell cycle arrest in NSCLC cells and can significantly downregulate phosphorylated retinoblastoma (RB) protein, thereby inhibiting the growth of NSCLC xenografts (80).